Developments in plastic surgery are dependent upon clinical trials that demonstrate the safety and efficacy of a new drug or device. Dr. Teitelbaum has been able to offer patients a number of these drugs and devices:
- McGhan Medical Corporation Style 410 Silicone Filled Breast Implant Clinical Study (Style 410 breast implant for first time and revision breast augmentation): ENROLLMENT CLOSED - Approved by the FDA 2012, Implants available
- Inamed Corporation Style 410 Silicone filled Breast Implant Continued Access Reconstruction/Revision Expansion Clinical Study (Style 410 breast implant study for revision and reconstruction only): ENROLLMENT CLOSED - Approved by the FDA 2012, Implants Available
- Sientra/Silimed Gel Filled Mammary Implant Study (Sientra highly cohesive gel study for primary and secondary breast augmentation): ENROLLMENT CLOSED - Approved by FDA 2012 - Implants Available
- Contour Profile Cohesive Gel Mammary Prosthesis Clinical Trial IDE G010149 Study # A105-0601-3 (Mentor CPG highly cohesive gel implant study for primary and secondary augmentation and reconstruction): ENROLLMENT CLOSED - Approved by the FDA 2012 - Implants Available
- Kythera CT990611 Protocol No ATX-101-11-26 Open Label (injection of fat-dissolving drug into neck): ENROLLMENT CLOSED
- UltraShape Core Clinical Study (examination of focused ultrasound for body contouring by permanent fat disruption): ENROLLMENT CLOSED
- Kythera Dosing Study (injection of fat dissolving drug into tummy tuck patient's area to be excised prior to surgery to study dosage and timing of effect): ENROLLMENT CLOSED
Dr. Teitelbaum was the lead author on this paper investigating the success of the first non-invasive fat reduction device.
© Steven Teitelbaum MD, A Medical Corporation. All Rights Reserved. Designed & Developed by Studio III in collaboration with air conditioned la